A detailed history of Ubs Group Ag transactions in Essa Pharma Inc. stock. As of the latest transaction made, Ubs Group Ag holds 95,614 shares of EPIX stock, worth $156,806. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95,614
Previous 2,417 3855.9%
Holding current value
$156,806
Previous $14,000 1121.43%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$1.4 - $6.23 $130,475 - $580,617
93,197 Added 3855.9%
95,614 $171,000
Q3 2024

Nov 14, 2024

BUY
$4.45 - $7.1 $3,791 - $6,049
852 Added 54.44%
2,417 $14,000
Q2 2024

Aug 13, 2024

SELL
$4.63 - $8.42 $9,542 - $17,353
-2,061 Reduced 56.84%
1,565 $8,000
Q1 2024

May 13, 2024

SELL
$6.17 - $10.65 $7,829 - $13,514
-1,269 Reduced 25.92%
3,626 $30,000
Q4 2023

Feb 09, 2024

BUY
$2.74 - $7.35 $12,960 - $34,765
4,730 Added 2866.67%
4,895 $32,000
Q3 2023

Nov 09, 2023

SELL
$2.65 - $3.31 $702 - $877
-265 Reduced 61.63%
165 $0
Q2 2023

Aug 11, 2023

SELL
$2.6 - $3.34 $7,342 - $9,432
-2,824 Reduced 86.79%
430 $1,000
Q1 2023

May 12, 2023

SELL
$2.56 - $3.55 $8,366 - $11,601
-3,268 Reduced 50.11%
3,254 $9,000
Q4 2022

Feb 08, 2023

BUY
$1.5 - $4.82 $9,783 - $31,436
6,522 New
6,522 $16,000
Q2 2022

Aug 10, 2022

SELL
$3.15 - $7.94 $9,106 - $22,954
-2,891 Reduced 9.19%
28,551 $90,000
Q1 2022

May 16, 2022

BUY
$6.18 - $14.44 $2,033 - $4,750
329 Added 1.06%
31,442 $194,000
Q4 2021

Feb 14, 2022

BUY
$7.8 - $14.38 $126,570 - $233,344
16,227 Added 109.01%
31,113 $442,000
Q3 2021

Nov 15, 2021

SELL
$7.76 - $29.37 $334,875 - $1.27 Million
-43,154 Reduced 74.35%
14,886 $119,000
Q2 2021

Aug 13, 2021

BUY
$24.17 - $34.28 $1.38 Million - $1.96 Million
57,172 Added 6586.64%
58,040 $1.66 Million
Q1 2021

May 12, 2021

BUY
$11.61 - $32.08 $5,387 - $14,885
464 Added 114.85%
868 $25,000
Q4 2020

Feb 11, 2021

SELL
$5.47 - $12.1 $12,838 - $28,398
-2,347 Reduced 85.31%
404 $5,000
Q3 2020

Nov 12, 2020

BUY
$6.0 - $7.79 $16,506 - $21,430
2,751 New
2,751 $19,000
Q2 2020

Jul 31, 2020

SELL
$3.71 - $6.2 $6,028 - $10,075
-1,625 Closed
0 $0
Q1 2020

May 01, 2020

BUY
$3.23 - $5.87 $2,948 - $5,359
913 Added 128.23%
1,625 $7,000
Q4 2019

Feb 14, 2020

BUY
$3.05 - $6.0 $2,171 - $4,272
712 New
712 $4,000

Others Institutions Holding EPIX

About ESSA Pharma Inc.


  • Ticker EPIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,073,100
  • Market Cap $72.3M
  • Description
  • ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...
More about EPIX
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.